We disclose a diagnostic test to determine suitable therapeutic intervention of subjects suffering from subclinical Cushings syndrome [SCS] and also agents that antagonize the action of cortisol or inhibit excess cortisol production in the treatment of conditions such as SCS in the presence of an adrenal incidentaloma.
